# US 2024/0200019 A1 · Genetically modified yeast cells and methods of use for increased lipid yield

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0200019 A1
- Document ID: US20240200019A1
- Status: Published application
- Kind: A1
- Application number: 18/288,954
- Filed: 2022-04-28
- Published: 2024-06-20
- Earliest claimed: 2021-04-29
- Assignees: Ginkgo Bioworks, Inc.
- Applicants: Ginkgo Bioworks, Inc.
- Inventors: Annapurna Kamineni; Arthur J. Shaw; Vasiliki Tsakraklides
- Web page: https://patentgrep.com/patent/US20240200019A1

## CPC

- C12N 1/165: Yeast isolates
- C12N 9/1029: {transferring groups other than amino-acyl groups (2.3.1)}
- C12N 9/88: Lyases (4.)
- C12N 15/815: {for yeasts other than Saccharomyces}
- C12P 5/007: {containing one or more isoprene units, i.e. terpenes (carotenes C12P23/00)}
- C12P 7/04: acyclic
- C12P 7/6409: Fatty acids
- C12P 7/6454: by esterification
- C12P 7/6463: obtained from glyceride producing microorganisms, e.g. single cell oil
- C12Y 401/02022: Fructose-6-phosphate phosphoketolase (4.1.2.22)
- C07K 2319/00: Fusion polypeptide
- C12R 2001/645: Fungi {; Processes using fungi}
- C12Y 203/01008: Phosphate acetyltransferase (2.3.1.8)
- C12Y 401/02009: Phosphoketolase (4.1.2.9)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Y: ENZYMES
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS

## Abstract

Aspects of the disclosure are directed to genetically modified yeast cells and methods for use. Certain aspects are directed to recombinant yeast cells comprising exogenous nucleic acid sequences encoding phosphotransacetylase and/or phosphoketolase proteins, including a phosphoketolase protein from Clostridium acetobutylicum. Also disclosed are methods for generating recombinant yeast cells and methods of use of such cells for production of one or more products, including lipids, oils, fatty acids, and triacylglycerides.

## Claims

### Claim 1

A recombinant yeast cell, comprising:
(a) a first exogenous nucleic acid sequence encoding a phosphoketolase protein comprising a sequence having at least 90% sequence identity to SEQ ID NO:28; and
(b) a second exogenous nucleic acid sequence encoding a phosphotransacetylase protein.

### Claim 2 (depends on 1)

The recombinant yeast cell of claim 1, wherein the phosphoketolase protein and the phosphotransacetylase protein are expressed by the recombinant yeast cell as separate proteins.

### Claim 3 (depends on 1)

The recombinant yeast cell of claim 1, wherein the phosphoketolase protein and the phosphotransacetylase protein are expressed by the recombinant yeast cell as a fusion protein.

### Claim 4 (depends on 3)

The recombinant yeast cell of claim 3, wherein the fusion protein comprises the phosphoketolase protein attached to the phosphotransacetylase protein via a linker.

### Claim 5 (depends on 1, 2, 3, 4)

The recombinant yeast cell of any of claims 1-4, wherein the phosphoketolase protein comprises a sequence having at least 95% identity to SEQ ID NO:28.

### Claim 6 (depends on 5)

The recombinant yeast cell of claim 5, wherein the phosphoketolase protein comprises a sequence having at least 98% identity to SEQ ID NO:28.

### Claim 7 (depends on 6)

The recombinant yeast cell of claim 6, wherein the phosphoketolase protein comprises a sequence having at least 99% identity to SEQ ID NO:28.

### Claim 8 (depends on 7)

The recombinant yeast cell of claim 7, wherein the phosphoketolase protein comprises SEQ ID NO:28.

### Claim 9 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

The recombinant yeast cell of any of claims 1-8, wherein the first exogenous nucleic acid sequence comprises a sequence having at least 75% identity to SEQ ID NO:26.

### Claim 10 (depends on 9)

The recombinant yeast cell of claim 9, wherein the first exogenous nucleic acid sequence comprises a sequence having at least 80% identity to SEQ ID NO:26.

### Claim 11 (depends on 10)

The recombinant yeast cell of claim 10, wherein the first exogenous nucleic acid sequence comprises a sequence having at least 90% identity to SEQ ID NO:26.

### Claim 12 (depends on 11)

The recombinant yeast cell of claim 11, wherein the first exogenous nucleic acid sequence comprises a sequence having at least 95% identity to SEQ ID NO:26.

### Claim 13 (depends on 12)

The recombinant yeast cell of claim 12, wherein the first exogenous nucleic acid sequence comprises SEQ ID NO:26.

### Claim 14 (depends on 13)

The recombinant yeast cell of claim 13, wherein the first exogenous nucleic acid sequence comprises two copies of SEQ ID NO:26.

### Claim 15 (depends on 13)

The recombinant yeast cell of claim 13, wherein the first exogenous nucleic acid sequence comprises three copies of SEQ ID NO:26.

### Claim 16 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

The recombinant yeast cell of any of claims 1-8, wherein the first exogenous nucleic acid sequence comprises a sequence having at least 75% identity to SEQ ID NO:27.

### Claim 17 (depends on 16)

The recombinant yeast cell of claim 16, the first exogenous nucleic acid sequence comprises a sequence having at least 80% identity to SEQ ID NO:27.

### Claim 18 (depends on 17)

The recombinant yeast cell of claim 17, wherein the first exogenous nucleic acid sequence comprises a sequence having at least 90% identity to SEQ ID NO:27.

### Claim 19 (depends on 18)

The recombinant yeast cell of claim 18, wherein the first exogenous nucleic acid sequence comprises a sequence having at least 95% identity to SEQ ID NO:27.

### Claim 20 (depends on 19)

The recombinant yeast cell of claim 19, wherein the first exogenous nucleic acid sequence comprises SEQ ID NO:27.

### Claim 21 (depends on 20)

The recombinant yeast cell of claim 20, wherein the first exogenous nucleic acid sequence comprises two copies of SEQ ID NO:27.

### Claim 22 (depends on 20)

The recombinant yeast cell of claim 20, wherein the first exogenous nucleic acid sequence comprises three copies of SEQ ID NO:27.

### Claim 23 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22)

The recombinant yeast cell of any of claims 1-22, wherein the phosphotransacetylase protein comprises a sequence having at least 90% identity to SEQ ID NO:29.

### Claim 24 (depends on 23)

The recombinant yeast cell of claim 23, wherein the phosphotransacetylase protein comprises a sequence having at least 95% identity to SEQ ID NO:29

### Claim 25 (depends on 24)

The recombinant yeast cell of claim 24, wherein the phosphotransacetylase protein comprises a sequence having at least 98% identity to SEQ ID NO:29

### Claim 26 (depends on 25)

The recombinant yeast cell of claim 25, wherein the phosphotransacetylase protein comprises SEQ ID NO:29

### Claim 27 (depends on 23, 24, 25, 26)

The recombinant yeast cell of any of claims 23-26, wherein the second exogenous nucleic acid sequence comprises a sequence having at least 75% identity to SEQ ID NO:23.

### Claim 28 (depends on 27)

The recombinant yeast cell of claim 27, wherein the second exogenous nucleic acid sequence comprises a sequence having at least 80% identity to SEQ ID NO:23.

### Claim 29 (depends on 28)

The recombinant yeast cell of claim 28, wherein the second exogenous nucleic acid sequence comprises a sequence having at least 90% identity to SEQ ID NO:23.

### Claim 30 (depends on 29)

The recombinant yeast cell of claim 29, wherein the second exogenous nucleic acid sequence comprises a sequence having at least 95% identity to SEQ ID NO:23.

### Claim 31 (depends on 30)

The recombinant yeast cell of claim 30, wherein the second exogenous nucleic acid sequence comprises SEQ ID NO:23.

### Claim 32 (depends on 31)

The recombinant yeast cell of claim 31, wherein the second exogenous nucleic acid sequence comprises two copies of SEQ ID NO:23.

### Claim 33 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22)

The recombinant yeast cell of any of claims 1-22, wherein the phosphotransacetylase protein comprises a sequence having at least 90% to SEQ ID NO:30.

### Claim 34 (depends on 33)

The recombinant yeast cell of claim 33, wherein the phosphotransacetylase protein comprises a sequence having at least 95% identity to SEQ ID NO:30.

### Claim 35 (depends on 34)

The recombinant yeast cell of claim 34, wherein the phosphotransacetylase protein comprises a sequence having at least 98% identity to SEQ ID NO:30.

### Claim 36 (depends on 36)

The recombinant yeast cell of claim 36, wherein the phosphotransacetylase protein comprises SEQ ID NO:30.

### Claim 37 (depends on 33, 34, 35, 36)

The recombinant yeast cell of any of claims 33-36, wherein the second exogenous nucleic acid sequence comprises a sequence having at least 75% identity to SEQ ID NO:24.

### Claim 38 (depends on 37)

The recombinant yeast cell of claim 37, wherein the second exogenous nucleic acid sequence comprises a sequence having at least 80% identity to SEQ ID NO:24.

### Claim 39 (depends on 38)

The recombinant yeast cell of claim 38, wherein the second exogenous nucleic acid sequence comprises a sequence having at least 90% identity to SEQ ID NO:24.

### Claim 40 (depends on 39)

The recombinant yeast cell of claim 39, wherein the second exogenous nucleic acid sequence comprises a sequence having at least 95% identity to SEQ ID NO:24.

### Claim 41 (depends on 40)

The recombinant yeast cell of claim 40, wherein the second exogenous nucleic acid sequence comprises SEQ ID NO:24.

### Claim 42 (depends on 41)

The recombinant yeast cell of claim 41, wherein the second exogenous nucleic acid sequence comprises two copies of SEQ ID NO:24.

### Claim 43 (depends on 33, 34, 35, 36)

The recombinant yeast cell of any of claims 33-36, wherein the second exogenous nucleic acid sequence comprises a sequence having at least 75% identity to SEQ ID NO:25.

### Claim 44 (depends on 43)

The recombinant yeast cell of claim 43, wherein the second exogenous nucleic acid sequence comprises a sequence having at least 80% identity to SEQ ID NO:25.

### Claim 45 (depends on 44)

The recombinant yeast cell of claim 44, wherein the second exogenous nucleic acid sequence comprises a sequence having at least 90% identity to SEQ ID NO:25.

### Claim 46 (depends on 45)

The recombinant yeast cell of claim 45, wherein the second exogenous nucleic acid sequence comprises a sequence having at least 95% identity to SEQ ID NO:25.

### Claim 47 (depends on 46)

The recombinant yeast cell of claim 46, wherein the second exogenous nucleic acid sequence comprises SEQ ID NO:25.

### Claim 48 (depends on 47)

The recombinant yeast cell of claim 47, wherein the second exogenous nucleic acid sequence comprises two copies of SEQ ID NO:25.

### Claim 49

The recombinant yeast cell of any of claims, wherein the recombinant yeast cell has reduced expression of an endogenous functional phosphofructokinase protein compared to a wild type yeast cell.

### Claim 50 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49)

The recombinant yeast cell of any of claims 1-49, wherein the recombinant yeast cell does not express an endogenous functional phosphofructokinase protein.

### Claim 51 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50)

The recombinant yeast cell of any of claims 1-50, wherein the recombinant yeast cell is an Arxula cell, a Saccharomyces cell, or a Yarrowia cell.

### Claim 52 (depends on 51)

The recombinant yeast cell of claim 51, wherein the yeast cell is a Arxula cell.

### Claim 53 (depends on 52)

The recombinant yeast cell of claim 52, wherein the recombinant yeast cell is Arxula adeninivorans

### Claim 54 (depends on 52, 53)

The recombinant yeast cell of claim 52 or 53, wherein the first exogenous nucleic acid sequence does not comprise one or more of TTA, ATA, and AGG.

### Claim 55 (depends on 54)

The recombinant yeast cell of claim 54, wherein the first exogenous nucleic acid sequence does not comprise any of TTA, ATA, and AGG.

### Claim 56 (depends on 51)

The recombinant yeast cell of claim 51, wherein the yeast cell is a Saccharomyces cell.

### Claim 57 (depends on 56)

The recombinant yeast cell of claim 56, wherein the recombinant yeast cell is Saccharomyces cerevisiae.

### Claim 58 (depends on 56, 57)

The recombinant yeast cell of claim 56 or 57, wherein the first exogenous nucleic acid sequence does not comprise one or more of CGC, CGA, and TCG.

### Claim 59 (depends on 58)

The recombinant yeast cell of claim 58, wherein the first exogenous nucleic acid sequence does not comprise any of CGC, CGA, and TCG.

### Claim 60 (depends on 51)

The recombinant yeast cell of claim 51, wherein the yeast cell is a Yarrowia cell,

### Claim 61 (depends on 60)

The recombinant yeast cell of claim 60, wherein the recombinant yeast cell is Yarrowia lipolytica.

### Claim 62 (depends on 60, 61)

The recombinant yeast cell of claim 60 or 61, wherein the first exogenous nucleic acid sequence does not comprise one or more of ATA, CTA, and AGT.

### Claim 63 (depends on 61)

The recombinant yeast cell of claim 61 wherein the first exogenous nucleic acid sequence does not comprise any of ATA, CTA, and AGT.

### Claim 64 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63)

The recombinant yeast cell of any of claims 1-63, wherein the recombinant yeast cell is Arxula adeninivorans, Saccharomyces cerevisiae, or Yarrowia lipolytica.

### Claim 65 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64)

The recombinant yeast cell of any of claims 1-64, wherein the recombinant yeast cell is Yarrowia lipolytica.

### Claim 66 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65)

The recombinant yeast cell of any of claims 1-65, wherein the first exogenous nucleic acid sequence and the second exogenous nucleic acid sequence are on a single expression cassette.

### Claim 67 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65)

The recombinant yeast cell of any of claims 1-65, wherein the first exogenous nucleic acid sequence and the second exogenous nucleic acid sequence are controlled by a single promoter.

### Claim 68 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65)

The recombinant yeast cell of any of claims 1-65, wherein the first exogenous nucleic acid sequence and the second exogenous nucleic acid sequence are on different expression cassettes.

### Claim 69 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65)

The recombinant yeast cell of any of claims 1-65, wherein the first exogenous nucleic acid sequence and the second exogenous nucleic acid sequence are controlled by different promoters.

### Claim 70 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69)

A method for generating the recombinant yeast cell of any of claims 1-69, the method comprising transforming a yeast cell with the first exogenous nucleic acid sequence and the second exogenous nucleic acid sequence.

### Claim 71 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69)

A method for expressing a phosphoketolase protein and a phosphotransacetylase protein, the method comprising culturing the recombinant yeast cell of any of claims 1-69 under conditions sufficient to express the first exogenous nucleic acid sequence and the second exogenous nucleic acid sequence.

### Claim 72 (depends on 71)

The method of claim 71, wherein the method comprises culturing the recombinant yeast cell for at least 10 passages.

### Claim 73

A method for collecting an acetyl-CoA derived product from a yeast cell, the method comprising:
(a) culturing a recombinant yeast cell comprising:
(i) a first exogenous nucleic acid sequence encoding a phosphoketolase protein comprising a sequence having at least 90% sequence identity to SEQ ID NO:28; and
(ii) a second exogenous nucleic acid sequence encoding a phosphotransacetylase protein
under conditions sufficient to express the first exogenous nucleic acid sequence and the second exogenous nucleic acid sequence; and
(b) collecting the acetyl-CoA derived product from the yeast cell.

### Claim 74 (depends on 73)

The method of claim 73, wherein the phosphoketolase protein comprises a sequence having at least 95% identity to SEQ ID NO:28.

### Claim 75 (depends on 74)

The method of claim 74, wherein the phosphoketolase protein comprises a sequence having at least 98% identity to SEQ ID NO:28.

### Claim 76 (depends on 75)

The method of claim 75, wherein the phosphoketolase protein comprises a sequence having at least 99% identity to SEQ ID NO:28.

### Claim 77 (depends on 76)

The method of claim 76, wherein the phosphoketolase protein comprises SEQ ID NO:28.

### Claim 78 (depends on 73, 74, 75, 76, 77)

The method of any of claims 73-77, wherein the first exogenous nucleic acid sequence comprises a sequence having at least 75% identity to SEQ ID NO:26.

### Claim 79 (depends on 78)

The method of claim 78, wherein the first exogenous nucleic acid sequence comprises a sequence having at least 80% identity to SEQ ID NO:26.

### Claim 80 (depends on 79)

The method of claim 79, wherein the first exogenous nucleic acid sequence comprises a sequence having at least 90% identity to SEQ ID NO:26.

### Claim 81 (depends on 80)

The method of claim 80, wherein the first exogenous nucleic acid sequence comprises a sequence having at least 95% identity to SEQ ID NO:26.

### Claim 82 (depends on 81)

The method of claim 81, wherein the first exogenous nucleic acid sequence comprises SEQ ID NO:26.

### Claim 83 (depends on 82)

The method of claim 82, wherein the first exogenous nucleic acid sequence comprises two copies of SEQ ID NO:26.

### Claim 84 (depends on 82)

The method of claim 82, wherein the first exogenous nucleic acid sequence comprises three copies of SEQ ID NO:26.

### Claim 85 (depends on 73, 74, 75, 76, 77)

The method of any of claims 73-77, wherein the first exogenous nucleic acid sequence comprises a sequence having at least 75% identity to SEQ ID NO:27.

### Claim 86 (depends on 85)

The method of claim 85, wherein the first exogenous nucleic acid sequence comprises a sequence having at least 80% identity to SEQ ID NO:27.

### Claim 87 (depends on 86)

The method of claim 86, wherein the first exogenous nucleic acid sequence comprises a sequence having at least 90% identity to SEQ ID NO:27.

### Claim 88 (depends on 87)

The method of claim 87, wherein the first exogenous nucleic acid sequence comprises a sequence having at least 95% identity to SEQ ID NO:27.

### Claim 89 (depends on 75)

The method of claim 75, wherein the first exogenous nucleic acid sequence comprises SEQ ID NO:27.

### Claim 90 (depends on 89)

The method of claim 89, wherein the first exogenous nucleic acid sequence comprises two copies of SEQ ID NO:27.

### Claim 91 (depends on 89)

The method of claim 89, wherein the first exogenous nucleic acid sequence comprises three copies of SEQ ID NO:27.

### Claim 92 (depends on 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91)

The method of claim 73-91, wherein the phosphotransacetylase protein comprises a sequence having at least 90% identity to SEQ ID NO:29.

### Claim 93 (depends on 92)

The method of claim 92, wherein the phosphotransacetylase protein comprises a sequence having at least 95% identity to SEQ ID NO:29

### Claim 94 (depends on 93)

The method of claim 93, wherein the phosphotransacetylase protein comprises a sequence having at least 98% identity to SEQ ID NO:29

### Claim 95 (depends on 94)

The method of claim 94, wherein the phosphotransacetylase protein comprises SEQ ID NO:29

### Claim 96 (depends on 92, 93, 94, 95)

The method of any of claims 92-95, wherein the second exogenous nucleic acid sequence comprises SEQ ID NO:23.

### Claim 97 (depends on 96)

The method of claim 96, wherein the second exogenous nucleic acid sequence comprises two copies of SEQ ID NO:23.

### Claim 98 (depends on 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91)

The method of any of claims 73-91, wherein the phosphotransacetylase protein comprises a sequence having at least 90% to SEQ ID NO:30.

### Claim 99 (depends on 98)

The method of claim 98, wherein the phosphotransacetylase protein comprises a sequence having at least 95% identity to SEQ ID NO:30.

### Claim 100 (depends on 99)

The method of claim 99, wherein the phosphotransacetylase protein comprises a sequence having at least 98% identity to SEQ ID NO:30.

### Claim 101 (depends on 100)

The method of claim 100, wherein the phosphotransacetylase protein comprises SEQ ID NO:30.

### Claim 102 (depends on 98, 99, 100, 101)

The method of any of claims 98-101, wherein the second exogenous nucleic acid sequence comprises a sequence having at least 75% identity to SEQ ID NO:24.

### Claim 103 (depends on 102)

The method of claim 102, wherein the second exogenous nucleic acid sequence comprises a sequence having at least 80% identity to SEQ ID NO:24.

### Claim 104 (depends on 103)

The method of claim 103, wherein the second exogenous nucleic acid sequence comprises a sequence having at least 90% identity to SEQ ID NO:24.

### Claim 105 (depends on 104)

The method of claim 104, wherein the second exogenous nucleic acid sequence comprises a sequence having at least 95% identity to SEQ ID NO:24.

### Claim 106 (depends on 105)

The method of claim 105, wherein the second exogenous nucleic acid sequence comprises SEQ ID NO:24.

### Claim 107 (depends on 106)

The method of claim 106, wherein the second exogenous nucleic acid sequence comprises two copies of SEQ ID NO:24.

### Claim 108 (depends on 98, 99, 100, 101)

The method of any of claims 98-101, wherein the second exogenous nucleic acid sequence comprises a sequence having at least 75% identity to SEQ ID NO:25.

### Claim 109 (depends on 108)

The method of claim 108, wherein the second exogenous nucleic acid sequence comprises a sequence having at least 80% identity to SEQ ID NO:25.

### Claim 110 (depends on 109)

The method of claim 109, wherein the second exogenous nucleic acid sequence comprises a sequence having at least 90% identity to SEQ ID NO:25.

### Claim 111 (depends on 110)

The method of claim 110, wherein the second exogenous nucleic acid sequence comprises a sequence having at least 95% identity to SEQ ID NO:25.

### Claim 112 (depends on 111)

The method of claim 111, wherein the second exogenous nucleic acid sequence comprises SEQ ID NO:25.

### Claim 113 (depends on 112)

The method of claim 112, wherein the second exogenous nucleic acid sequence comprises two copies of SEQ ID NO:25.

### Claim 114 (depends on 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113)

The method of any of claims 73-113, wherein the recombinant yeast cell has reduced expression of an endogenous functional phosphofructokinase protein compared to a wild type yeast cell.

### Claim 115 (depends on 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114)

The method of any of claims 73-114, wherein the recombinant yeast cell does not express a functional endogenous phosphofructokinase protein.

### Claim 116 (depends on 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115)

The method of any of claims 73-115, further comprising, prior to (a), transforming a yeast cell with the first exogenous nucleic acid sequence and the second exogenous nucleic acid sequence.

### Claim 117 (depends on 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116)

The method of any of claims 73-116, further comprising, prior to (c), eliminating expression of a functional endogenous phosphofructokinase protein in the yeast cell.

### Claim 118 (depends on 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117)

The method of any of claims 73-117, wherein the recombinant yeast cell is an Arxula cell, a Saccharomyces cell, or a Yarrowia cell.

### Claim 119 (depends on 118)

The method of claim 118, wherein the yeast cell is a Arxula cell.

### Claim 120 (depends on 119)

The method of claim 119, wherein the recombinant yeast cell is Arxula adeninivorans

### Claim 121 (depends on 119, 120)

The method of claim 119 or 120, wherein the first exogenous nucleic acid sequence does not comprise one or more of TTA, ATA, and AGG.

### Claim 122 (depends on 121)

The method of claim 121, wherein the first exogenous nucleic acid sequence does not comprise any of TTA, ATA, and AGG.

### Claim 123 (depends on 118)

The method of claim 118, wherein the yeast cell is a Saccharomyces cell.

### Claim 124 (depends on 123)

The method of claim 123, wherein the recombinant yeast cell is Saccharomyces cerevisiae.

### Claim 125 (depends on 123, 124)

The method of claim 123 or 124, wherein the first exogenous nucleic acid sequence does not comprise one or more of CGC, CGA, and TCG.

### Claim 126 (depends on 125)

The method of claim 125, wherein the first exogenous nucleic acid sequence does not comprise any of CGC, CGA, and TCG.

### Claim 127 (depends on 118)

The method of claim 118, wherein the yeast cell is a Yarrowia cell,

### Claim 128 (depends on 127)

The method of claim 127, wherein the recombinant yeast cell is Yarrowia lipolytica.

### Claim 129 (depends on 127, 128)

The method of claim 127 or 128, wherein the first exogenous nucleic acid sequence does not comprise one or more of ATA, CTA, and AGT.

### Claim 130 (depends on 129)

The method of claim 129 wherein the first exogenous nucleic acid sequence does not comprise any of ATA, CTA, and AGT.

### Claim 131 (depends on 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130)

The method of any of claims 73-130, wherein, prior to (b), the yeast cell is cultured for at least 10 passages.

### Claim 132 (depends on 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131)

The method of any of claims 73-131, wherein the acetyl-CoA derived product is an oil.

### Claim 133 (depends on 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131)

The method of any of claims 73-131, wherein the acetyl-CoA derived product is a lipid.

### Claim 134 (depends on 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131)

The method of any of claims 73-131, wherein the acetyl-CoA derived product is a fatty acid.

### Claim 135 (depends on 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131)

The method of any of claims 73-131, wherein the acetyl-CoA derived product is a fatty alcohol.

### Claim 136 (depends on 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131)

The method of any of claims 73-131, wherein the acetyl-CoA derived product is a triacylglyceride.

### Claim 137 (depends on 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131)

The method of any of claims 73-131, wherein the acetyl-CoA derived product is triolein.

### Claim 138 (depends on 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131)

The method of any of claims 73-131, wherein the acetyl-CoA derived product is a terpene.

### Claim 139 (depends on 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138)

The method of any of claims 73-138, wherein the first exogenous nucleic acid sequence and the second exogenous nucleic acid sequence are on a single expression cassette.

### Claim 140 (depends on 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138)

The method of any of claims 73-138, wherein the first exogenous nucleic acid sequence and the second exogenous nucleic acid sequence are controlled by a single promoter.

### Claim 141 (depends on 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138)

The method of any of claims 73-138, wherein the first exogenous nucleic acid sequence and the second exogenous nucleic acid sequence are on different expression cassettes.

### Claim 142 (depends on 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138)

The method of any of claims 73-138, wherein the first exogenous nucleic acid sequence and the second exogenous nucleic acid sequence are controlled by different promoters.

### Claim 143

A recombinant Yarrowia lipolytica cell, comprising:
(a) a first exogenous nucleic acid sequence encoding a phosphoketolase protein from Clostridium acetobutylicum, wherein the first exogenous nucleic acid sequence comprises a sequence having at least 95% identity to SEQ ID NO:27; and
(b) a second exogenous nucleic acid sequence encoding (i) a phosphotransacetylase protein from Bacillus subtilis or (ii) a phosphotransacetylase protein from Thermoanaerobacterium saccharolyticum.

### Claim 144 (depends on 143)

The recombinant Yarrowia lipolytica cell of claim 143, wherein the first exogenous nucleic acid sequence comprises a sequence having at least 97% identity to SEQ ID NO:27.

### Claim 145 (depends on 144)

The recombinant Yarrowia lipolytica cell of claim 144, wherein the first exogenous nucleic acid sequence comprises a sequence having at least 98% identity to SEQ ID NO:27.

### Claim 146 (depends on 145)

The recombinant Yarrowia lipolytica cell of claim 145, wherein the first exogenous nucleic acid sequence comprises a sequence having at least 99% identity to SEQ ID NO:27.

### Claim 147 (depends on 146)

The recombinant Yarrowia lipolytica cell of claim 146, wherein the first exogenous nucleic acid sequence comprises SEQ ID NO:27.

### Claim 148 (depends on 143, 144, 145, 146, 147)

The recombinant Yarrowia lipolytica cell of any of claims 143-147, wherein the second exogenous nucleic acid sequence comprises a sequence having at least 95% identity to SEQ ID NO:23.

### Claim 149 (depends on 148)

The recombinant Yarrowia lipolytica cell of any of claim 148, wherein the second exogenous nucleic acid sequence comprises a sequence having at least 98% identity to SEQ ID NO:23.

### Claim 150 (depends on 149)

The recombinant Yarrowia lipolytica cell of any of claim 149, wherein the second exogenous nucleic acid sequence comprises a sequence having at least 99% identity to SEQ ID NO:23.

### Claim 151 (depends on 150)

The recombinant Yarrowia lipolytica cell of any of claim 150, wherein the second exogenous nucleic acid sequence comprises SEQ ID NO:23.

### Claim 152 (depends on 143, 144, 145, 146, 147)

The recombinant Yarrowia lipolytica cell of any of claims 143-147, wherein the second exogenous nucleic acid sequence comprises a sequence having at least 95% identity to SEQ ID NO:24.

### Claim 153 (depends on 152)

The recombinant Yarrowia lipolytica cell of any of claim 152, wherein the second exogenous nucleic acid sequence comprises a sequence having at least 95% identity to SEQ ID NO:24.

### Claim 154 (depends on 153)

The recombinant Yarrowia lipolytica cell of any of claim 153, wherein the second exogenous nucleic acid sequence comprises a sequence having at least 98% identity to SEQ ID NO:24.

### Claim 155 (depends on 154)

The recombinant Yarrowia lipolytica cell of any of claim 154, wherein the second exogenous nucleic acid sequence comprises a sequence having at least 99% identity to SEQ ID NO:24.

### Claim 156 (depends on 155)

The recombinant Yarrowia lipolytica cell of any of claim 155, wherein the second exogenous nucleic acid sequence comprises SEQ ID NO:24.

### Claim 157 (depends on 143, 144, 145, 146, 147)

The recombinant Yarrowia lipolytica cell of any of claims 143-147, wherein the second exogenous nucleic acid sequence comprises a sequence having at least 95% identity to SEQ ID NO:25.

### Claim 158 (depends on 157)

The recombinant Yarrowia lipolytica cell of any of claim 157, wherein the second exogenous nucleic acid sequence comprises a sequence having at least 98% identity to SEQ ID NO:25.

### Claim 159 (depends on 158)

The recombinant Yarrowia lipolytica cell of any of claim 158, wherein the second exogenous nucleic acid sequence comprises a sequence having at least 99% identity to SEQ ID NO:25.

### Claim 160 (depends on 159)

The recombinant Yarrowia lipolytica cell of any of claim 159, wherein the second exogenous nucleic acid sequence comprises SEQ ID NO:25.

### Claim 161 (depends on 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160)

The recombinant Yarrowia lipolytica cell of any of claims 143-160, wherein the recombinant yeast cell does not express a functional endogenous phosphofructokinase protein.
